2021
DOI: 10.1186/s12891-021-04929-8
|View full text |Cite
|
Sign up to set email alerts
|

15-year survivorship analysis of an interspinous device in surgery for single-level lumbar disc herniation

Abstract: Background Interspinous devices have been introduced as alternatives to decompression or fusion in surgery for degenerative lumbar diseases. This study aimed to investigate 15-year survivorship and risk factors for reoperation of a Device for Intervertebral Assisted Motion (DIAM) in surgery for 1-level lumbar disc herniation (LDH). Methods A total of 94 patients (54 men and 40 women) underwent discectomy and DIAM implantation for 1-level LDH, with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Contraindications to surgical treatment and at the same time criteria for exclusion from the study were: (1) reduction in disc height > 60% at the involved level, (2) inflammation of the arachnoid membrane, (3) primary diagnosis of the cause of spinal discomfort other than DLSD in the involved segment, (4) DLSD requiring the surgical treatment of more than one level, (5) history of conservative treatment within 6 weeks before the planned surgery, (6) sequestration of herniated nucleus pulposus, (7) history of any surgery of the involved or adjacent level, (8) history of any intradiscal ablation procedure, (9) congenital or iatrogenic absence of posterior column elements (e.g., condition after resection of the intervertebral joint, spondylolysis, fracture, closed spina bifida), (10) underdevelopment or agenesis of the spinous process, (11) lower limb movement deficit, (12) cauda equina syndrome, (13) clinically significant peripheral neuropathy, ( 14) chronic ischemia of the lower extremities manifested by intermittent claudication, (15) history of traumatic fracture in L1-L5 segments, either compressive or with tearing, ( 16) lumbar scoliosis with a Cobb angle greater than 15 • , (17) established osteoporosis, osteopenia or osteomalacia, (18) obesity with a BMI of ≥40, (19) documented allergy to silicone, polyethylene, titanium or latex, (20) active bacterial infection, (21) active neoplastic disease or a history of neoplastic disease within the past 5 years including spinal neoplastic disease, (22) anesthetic contraindications to general anesthesia, and the lack of patients' informed consent.…”
Section: Qualification Proceduresmentioning
confidence: 99%
See 1 more Smart Citation
“…Contraindications to surgical treatment and at the same time criteria for exclusion from the study were: (1) reduction in disc height > 60% at the involved level, (2) inflammation of the arachnoid membrane, (3) primary diagnosis of the cause of spinal discomfort other than DLSD in the involved segment, (4) DLSD requiring the surgical treatment of more than one level, (5) history of conservative treatment within 6 weeks before the planned surgery, (6) sequestration of herniated nucleus pulposus, (7) history of any surgery of the involved or adjacent level, (8) history of any intradiscal ablation procedure, (9) congenital or iatrogenic absence of posterior column elements (e.g., condition after resection of the intervertebral joint, spondylolysis, fracture, closed spina bifida), (10) underdevelopment or agenesis of the spinous process, (11) lower limb movement deficit, (12) cauda equina syndrome, (13) clinically significant peripheral neuropathy, ( 14) chronic ischemia of the lower extremities manifested by intermittent claudication, (15) history of traumatic fracture in L1-L5 segments, either compressive or with tearing, ( 16) lumbar scoliosis with a Cobb angle greater than 15 • , (17) established osteoporosis, osteopenia or osteomalacia, (18) obesity with a BMI of ≥40, (19) documented allergy to silicone, polyethylene, titanium or latex, (20) active bacterial infection, (21) active neoplastic disease or a history of neoplastic disease within the past 5 years including spinal neoplastic disease, (22) anesthetic contraindications to general anesthesia, and the lack of patients' informed consent.…”
Section: Qualification Proceduresmentioning
confidence: 99%
“…Intradiscal procedures include chemonucleolysis, automatic percutaneous lumbar discectomy with nucleotome, percutaneous endoscopic discectomy, intradiscal endothermal therapy and laser disc decompression [19,20]. In the ever-growing array of surgical treatment options, one of the most commonly performed procedures today is interspinous stabilization with a dynamic-interspinous-stabilizer-type DIAM (device for intervertebral assisted motion) [21].…”
Section: Introductionmentioning
confidence: 99%
“…It has also been argued that using PDS devices can improve fusion by allowing for micromovements between endplates and prevent against implant failure through improved load sharing [ 10 , 11 ]. So far, various PDS systems have been described in the literature, encompassing semi-rigid rod systems used primarily for fusion and tension band-based posterior systems generally used as no-fusion technologies [ 12 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…During flexion, the DIAM™ device is an example of a lumbar device that decreases surgery complication motion at the implanted levels and the adjacent [13]. The long-term surgery complications of the DIAM™ device include higher reoperation, revision surgery, and higher cost-effectiveness [14]. This retrospective study evaluated the surgical outcomes and focused on the complications resulting from the long-term elevated intra-disk pressure that has been shown to be associated with the progression of lumbar disk degeneration.…”
Section: Introductionmentioning
confidence: 99%